It was found to be a biomarker for predicting severe COVID-19 in Japan by Sugiyama et al. IFN-λ3 upregulates PAMP-mediated production of proinflammatory cytokines that induce high expression of inflammatory mediators such as IL-6, IL-12, and TNF. This evidence concerns the gene IL6 and COVID-19.